Three-year Survival of Women with Breast Cancer in Basrah, Iraq

Jasim N Al-Asadi1, Sundus M Al-Mayah2

  • 1Department of Family and Community Medicine, College of Medicine, University of Basrah, Basrah,Iraq.

Oman Medical Journal
|July 31, 2020
PubMed

Insights

The three-year survival rate for breast cancer patients in Basrah, Iraq, was 83.3%. Advanced tumor stage and poorly differentiated tumors were linked to poorer survival outcomes in women with breast cancer.

Area of Science:

  • Oncology
  • Epidemiology

Background:

  • Breast cancer survival rates vary globally, with significant disparities between developed and developing countries.
  • Understanding local survival data is crucial for improving patient outcomes in specific regions like Basrah, Iraq.

Purpose of the Study:

  • To determine the three-year observed survival rate of women diagnosed with breast cancer in Basrah, Iraq.
  • To identify prognostic factors associated with breast cancer survival in this population.

Main Methods:

  • Retrospective data collection from the Oncology Center registry in Basrah.
  • Inclusion of 605 women diagnosed with breast cancer between 2013-2014, with follow-up until 2017.
  • Kaplan-Meier method for survival estimation and Cox regression for prognostic factor analysis.

Main Results:

  • The overall three-year observed survival rate was 83.3%.
  • 44.1% of patients presented with advanced tumor stages (III and IV).
  • Late stage (Stage IV vs. I) and poorly differentiated tumors were significantly associated with reduced survival (HR > 4).

Conclusions:

  • The three-year survival rate in Basrah is comparable to developing countries but lower than in developed nations.
  • Advanced tumor stage and poor tumor differentiation are significant predictors of decreased survival in Iraqi women with breast cancer.
Abstract